1945 - Fellow of the American Association for the Advancement of Science (AAAS)
His scientific interests lie mostly in Virology, Virus, Lassa virus, Lassa fever and Ebola virus. Karl M. Johnson performs multidisciplinary studies into Virology and Filoviridae in his work. The various areas that Karl M. Johnson examines in his Virus study include Host, Antibody, Outbreak and Microbiology.
His Lassa virus study integrates concerns from other disciplines, such as Infectivity and Mastomys. His Lassa fever research is multidisciplinary, incorporating perspectives in Hepatitis A and Hepatitis. His research in Viremia intersects with topics in Odds ratio and Immunoglobulin G, Immunoglobulin M.
His main research concerns Virology, Virus, Immunology, Antibody and Ebola virus. His Virology research incorporates elements of Serology, Respiratory system and Antigen. In the field of Virus, his study on Titer, Viremia and Hemagglutination overlaps with subjects such as Bolivian hemorrhagic fever.
His Immunology research includes themes of Tropics, Epidemiology and Pneumonia. His study in Antibody is interdisciplinary in nature, drawing from both Infectivity and Blood serum. The study incorporates disciplines such as Mastomys and Lassa fever in addition to Lassa virus.
The scientist’s investigation covers issues in Virology, Ebola virus, Virus, Outbreak and Virus classification. His research integrates issues of Comparative biology and Biography in his study of Virology. His work in the fields of Ebolavirus overlaps with other areas such as Filoviridae and Confusion.
His Virus research is multidisciplinary, relying on both Mucoprotein and Tissue culture. His work carried out in the field of Outbreak brings together such families of science as Transmission, Ecology, Disease reservoir and Family medicine. His studies examine the connections between Natural history and genetics, as well as such issues in Intensive care medicine, with regards to Viral hemorrhagic fever and Immunology.
Karl M. Johnson focuses on Virology, Outbreak, Ebola virus, Virus and Marburg virus. The Outbreak study combines topics in areas such as Ecology and Disease reservoir. As part of one scientific family, Karl M. Johnson deals mainly with the area of Ebola virus, narrowing it down to issues related to the Natural history, and often Ebola vaccine.
Karl M. Johnson combines subjects such as Transmission and Serology with his study of Virus. In the subject of general Marburg virus, his work in Lloviu virus is often linked to Lloviu cuevavirus, thereby combining diverse domains of study. His biological study spans a wide range of topics, including Family medicine, Biodefense, Epidemiology and Infection control.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Lassa fever. Effective therapy with ribavirin.
Joseph B Mccormick;I. J. King;P. A. Webb;C. L. Scribner.
The New England Journal of Medicine (1986)
Isolation of the Etiologic Agent of Korean Hemorrhagic Fever
Ho Wang Lee;Pyund Woo Lee;Karl M. Johnson.
The Journal of Infectious Diseases (1978)
Hemorrhagic Fever Viruses as Biological Weapons: Medical and Public Health Management
Luciana Borio;Thomas Inglesby;C. J. Peters;Alan L. Schmaljohn.
JAMA (2002)
A Prospective Study of the Epidemiology and Ecology of Lassa Fever
Joseph B. McCormick;Patricia A. Webb;John W. Krebs;Karl M. Johnson.
The Journal of Infectious Diseases (1987)
Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations.
Jens H. Kuhn;Stephan Becker;Hideki Ebihara;Thomas W. Geisbert.
Archives of Virology (2010)
A Case-Control Study of the Clinical Diagnosis and Course of Lassa Fever
Joseph B. McCormick;Isabel J. King;Patricia A. Webb;Karl M. Johnson.
The Journal of Infectious Diseases (1987)
ISOLATION AND PARTIAL CHARACTERISATION OF A NEW VIRUS CAUSING ACUTE HÆMORRHAGIC FEVER IN ZAIRE
K.M Johnson;J.V Lange;P.A Webb;F.A Murphy.
The Lancet (1977)
Isolation of Hantaan Virus, the Etiologic Agent of Korean Hemorrhagic Fever, from Wild Urban Rats
Ho Wang Lee;Luck Ju Baek;Karl M. Johnson.
The Journal of Infectious Diseases (1982)
Clinical Virology of Lassa Fever in Hospitalized Patients
Karl M. Johnson;Karl M. Johnson;Joseph B. McCormick;Joseph B. McCormick;Patricia A. Webb;Patricia A. Webb;Ethleen S. Smith;Ethleen S. Smith.
The Journal of Infectious Diseases (1987)
Lassa Virus Infection of Rhesus Monkeys: Pathogenesis and Treatment with Ribavirin
P. B. Jahrling;P. B. Jahrling;R. A. Hesse;R. A. Hesse;G. A. Eddy;G. A. Eddy;K. M. Johnson;K. M. Johnson.
The Journal of Infectious Diseases (1980)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
National Institutes of Health
The University of Texas Health Science Center at Houston
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Baylor College of Medicine
Centers for Disease Control and Prevention
United States Army Medical Research Institute of Infectious Diseases
United States Army Medical Research Institute of Infectious Diseases
Centers for Disease Control and Prevention
Claude Bernard University Lyon 1
United States Army Medical Research Institute of Infectious Diseases
Publications: 55
Boston University
Amirkabir University of Technology
Macquarie University
University of Maryland, College Park
Chalmers University of Technology
Maruzen Pharmaceuticals Co. Ltd.
Washington University in St. Louis
University of Leicester
Northwestern University
University of Arizona
Paul Sabatier University
University of Bern
Koç University
Icahn School of Medicine at Mount Sinai
Vanderbilt University Medical Center
Duke University